P Wave

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 249384 Experts worldwide ranked by ideXlab platform

Wen-chol Voon - One of the best experts on this subject based on the ideXlab platform.

  • P Wave disPersion and maximum P Wave duration are indePendently associated with raPid renal function decline.
    PloS one, 2012
    Co-Authors: Wei-chung Tsai, Tsung-hsien Lin, Po-chao Hsu, Wen-hsien Lee, Ming-yen Lin, Szu-chia Chen, Chee-siong Lee, Wen-chol Voon, Wen-ter Lai
    Abstract:

    The P Wave Parameters measured by 12-lead electrocardiogram (ECG) are commonly used as noninvasive tools to assess for left atrial enlargement. There are limited studies to evaluate whether P Wave Parameters are indePendently associated with decline in renal function. Accordingly, the aim of this study is to assess whether P Wave Parameters are indePendently associated with Progression to renal end Point of ≥25% decline in estimated glomerular filtration rate (eGFR). This longitudinal study included 166 Patients. The renal end Point was defined as ≥25% decline in eGFR. We measured two ECG P Wave Parameters corrected by heart rate, i.e. corrected P Wave disPersion (PWdisPerC) and corrected P Wave maximum duration (PWdurMaxC). Heart function and structure were measured from echocardiograPhy. Clinical data, P Wave Parameters, and echocardiograPhic measurements were comPared and analyzed. Forty-three Patients (25.9%) reached renal end Point. KaPlan-Meier curves for renal end Point-free survival showed PWdisPerC > median (63.0 ms) (log-rank P = 0.004) and PWdurMaxC > median (117.9 ms) (log-rank P

  • P Wave disPersion and maximum P Wave duration are indePendently associated with raPid renal function decline.
    PLOS ONE, 2012
    Co-Authors: Ho-ming Su, Wei-chung Tsai, Szu-chia Chen, Wen-chol Voon
    Abstract:

    The P Wave Parameters measured by 12-lead electrocardiogram (ECG) are commonly used as noninvasive tools to assess for left atrial enlargement. There are limited studies to evaluate whether P Wave Parameters are indePendently associated with decline in renal function. Accordingly, the aim of this study is to assess whether P Wave Parameters are indePendently associated with Progression to renal end Point of $25% decline in estimated glomerular filtration rate (eGFR). This longitudinal study included 166 Patients. The renal end Point was defined as $25% decline in eGFR. We measured two ECG P Wave Parameters corrected by heart rate, i.e. corrected P Wave disPersion (PWdisPerC) and corrected P Wave maximum duration (PWdurMaxC). Heart function and structure were measured from echocardiograPhy. Clinical data, P Wave Parameters, and echocardiograPhic measurements were comPared and analyzed. Forty-three Patients (25.9%) reached renal end Point. KaPlan-Meier curves for renal end Point-free survival showed PWdisPerC . median (63.0 ms) (log-rank P=0.004) and PWdurMaxC . median (117.9 ms) (log-rank P,0.001) were associated with Progression to renal end Point. Multivariate forward Cox-regression analysis identified increased PWdisPerC (hazard ratio [HR], 1.024; P=0.001) and PWdurMaxC (HR, 1.029; P=0.001) were indePendently associated with Progression to renal end Point. Our results demonstrate that increased PWdisPerC and PWdurMaxC were indePendently associated with Progression to renal end Point. Screening Patients by means of PWdisPerC and PWdurMaxC on 12 lead ECG may helP identify a high risk grouP of raPid renal function decline.

Szu-chia Chen - One of the best experts on this subject based on the ideXlab platform.

  • P Wave disPersion and maximum P Wave duration are associated with renal outcomes in chronic kidney disease.
    PLOS ONE, 2014
    Co-Authors: Jiun-chi Huang, Szu-chia Chen, Jer-ming Chang, Chi-chih Hung, Ho-ming Su, Shang-jyh Hwang, Hung-chun Chen
    Abstract:

    : P Wave Parameters measured by 12-lead electrocardiogram (ECG) are commonly used as a noninvasive tool to evaluate left atrial enlargement. This study was designed to assess whether P Wave Parameters were associated with renal outcomes in chronic kidney disease (CKD) Patients. This longitudinal study enrolled 439 Patients with CKD stages 3-5. Renal end Points were defined as the commencement of dialysis or death. Change in renal function was measured using the estimated glomerular filtration rate (eGFR) sloPe. We measured two ECG P Wave Parameters corrected for heart rate, i.e., corrected P Wave disPersion and corrected maximum P Wave duration. The values of P Wave disPersion and maximum P Wave duration were 88.8±21.7 ms and 153.3±21.7 ms, resPectively. During the follow-uP Period (mean, 25.2 months), 95 Patients (21.6%) started hemodialysis and 30 deaths (6.8%) were recorded. Multivariate Cox regression analysis identified that increased P Wave disPersion [hazard ratio (HR), 1.020; 95% confidence interval (CI), 1.009-1.032; P

  • P Wave disPersion and maximum P Wave duration are indePendently associated with raPid renal function decline.
    PloS one, 2012
    Co-Authors: Wei-chung Tsai, Tsung-hsien Lin, Po-chao Hsu, Wen-hsien Lee, Ming-yen Lin, Szu-chia Chen, Chee-siong Lee, Wen-chol Voon, Wen-ter Lai
    Abstract:

    The P Wave Parameters measured by 12-lead electrocardiogram (ECG) are commonly used as noninvasive tools to assess for left atrial enlargement. There are limited studies to evaluate whether P Wave Parameters are indePendently associated with decline in renal function. Accordingly, the aim of this study is to assess whether P Wave Parameters are indePendently associated with Progression to renal end Point of ≥25% decline in estimated glomerular filtration rate (eGFR). This longitudinal study included 166 Patients. The renal end Point was defined as ≥25% decline in eGFR. We measured two ECG P Wave Parameters corrected by heart rate, i.e. corrected P Wave disPersion (PWdisPerC) and corrected P Wave maximum duration (PWdurMaxC). Heart function and structure were measured from echocardiograPhy. Clinical data, P Wave Parameters, and echocardiograPhic measurements were comPared and analyzed. Forty-three Patients (25.9%) reached renal end Point. KaPlan-Meier curves for renal end Point-free survival showed PWdisPerC > median (63.0 ms) (log-rank P = 0.004) and PWdurMaxC > median (117.9 ms) (log-rank P

  • P Wave disPersion and maximum P Wave duration are indePendently associated with raPid renal function decline.
    PLOS ONE, 2012
    Co-Authors: Ho-ming Su, Wei-chung Tsai, Szu-chia Chen, Wen-chol Voon
    Abstract:

    The P Wave Parameters measured by 12-lead electrocardiogram (ECG) are commonly used as noninvasive tools to assess for left atrial enlargement. There are limited studies to evaluate whether P Wave Parameters are indePendently associated with decline in renal function. Accordingly, the aim of this study is to assess whether P Wave Parameters are indePendently associated with Progression to renal end Point of $25% decline in estimated glomerular filtration rate (eGFR). This longitudinal study included 166 Patients. The renal end Point was defined as $25% decline in eGFR. We measured two ECG P Wave Parameters corrected by heart rate, i.e. corrected P Wave disPersion (PWdisPerC) and corrected P Wave maximum duration (PWdurMaxC). Heart function and structure were measured from echocardiograPhy. Clinical data, P Wave Parameters, and echocardiograPhic measurements were comPared and analyzed. Forty-three Patients (25.9%) reached renal end Point. KaPlan-Meier curves for renal end Point-free survival showed PWdisPerC . median (63.0 ms) (log-rank P=0.004) and PWdurMaxC . median (117.9 ms) (log-rank P,0.001) were associated with Progression to renal end Point. Multivariate forward Cox-regression analysis identified increased PWdisPerC (hazard ratio [HR], 1.024; P=0.001) and PWdurMaxC (HR, 1.029; P=0.001) were indePendently associated with Progression to renal end Point. Our results demonstrate that increased PWdisPerC and PWdurMaxC were indePendently associated with Progression to renal end Point. Screening Patients by means of PWdisPerC and PWdurMaxC on 12 lead ECG may helP identify a high risk grouP of raPid renal function decline.

Wei-chung Tsai - One of the best experts on this subject based on the ideXlab platform.

  • P Wave disPersion and maximum P Wave duration are indePendently associated with raPid renal function decline.
    PloS one, 2012
    Co-Authors: Wei-chung Tsai, Tsung-hsien Lin, Po-chao Hsu, Wen-hsien Lee, Ming-yen Lin, Szu-chia Chen, Chee-siong Lee, Wen-chol Voon, Wen-ter Lai
    Abstract:

    The P Wave Parameters measured by 12-lead electrocardiogram (ECG) are commonly used as noninvasive tools to assess for left atrial enlargement. There are limited studies to evaluate whether P Wave Parameters are indePendently associated with decline in renal function. Accordingly, the aim of this study is to assess whether P Wave Parameters are indePendently associated with Progression to renal end Point of ≥25% decline in estimated glomerular filtration rate (eGFR). This longitudinal study included 166 Patients. The renal end Point was defined as ≥25% decline in eGFR. We measured two ECG P Wave Parameters corrected by heart rate, i.e. corrected P Wave disPersion (PWdisPerC) and corrected P Wave maximum duration (PWdurMaxC). Heart function and structure were measured from echocardiograPhy. Clinical data, P Wave Parameters, and echocardiograPhic measurements were comPared and analyzed. Forty-three Patients (25.9%) reached renal end Point. KaPlan-Meier curves for renal end Point-free survival showed PWdisPerC > median (63.0 ms) (log-rank P = 0.004) and PWdurMaxC > median (117.9 ms) (log-rank P

  • P Wave disPersion and maximum P Wave duration are indePendently associated with raPid renal function decline.
    PLOS ONE, 2012
    Co-Authors: Ho-ming Su, Wei-chung Tsai, Szu-chia Chen, Wen-chol Voon
    Abstract:

    The P Wave Parameters measured by 12-lead electrocardiogram (ECG) are commonly used as noninvasive tools to assess for left atrial enlargement. There are limited studies to evaluate whether P Wave Parameters are indePendently associated with decline in renal function. Accordingly, the aim of this study is to assess whether P Wave Parameters are indePendently associated with Progression to renal end Point of $25% decline in estimated glomerular filtration rate (eGFR). This longitudinal study included 166 Patients. The renal end Point was defined as $25% decline in eGFR. We measured two ECG P Wave Parameters corrected by heart rate, i.e. corrected P Wave disPersion (PWdisPerC) and corrected P Wave maximum duration (PWdurMaxC). Heart function and structure were measured from echocardiograPhy. Clinical data, P Wave Parameters, and echocardiograPhic measurements were comPared and analyzed. Forty-three Patients (25.9%) reached renal end Point. KaPlan-Meier curves for renal end Point-free survival showed PWdisPerC . median (63.0 ms) (log-rank P=0.004) and PWdurMaxC . median (117.9 ms) (log-rank P,0.001) were associated with Progression to renal end Point. Multivariate forward Cox-regression analysis identified increased PWdisPerC (hazard ratio [HR], 1.024; P=0.001) and PWdurMaxC (HR, 1.029; P=0.001) were indePendently associated with Progression to renal end Point. Our results demonstrate that increased PWdisPerC and PWdurMaxC were indePendently associated with Progression to renal end Point. Screening Patients by means of PWdisPerC and PWdurMaxC on 12 lead ECG may helP identify a high risk grouP of raPid renal function decline.

Ho-ming Su - One of the best experts on this subject based on the ideXlab platform.

  • P Wave disPersion and maximum P Wave duration are associated with renal outcomes in chronic kidney disease.
    PLOS ONE, 2014
    Co-Authors: Jiun-chi Huang, Szu-chia Chen, Jer-ming Chang, Chi-chih Hung, Ho-ming Su, Shang-jyh Hwang, Hung-chun Chen
    Abstract:

    : P Wave Parameters measured by 12-lead electrocardiogram (ECG) are commonly used as a noninvasive tool to evaluate left atrial enlargement. This study was designed to assess whether P Wave Parameters were associated with renal outcomes in chronic kidney disease (CKD) Patients. This longitudinal study enrolled 439 Patients with CKD stages 3-5. Renal end Points were defined as the commencement of dialysis or death. Change in renal function was measured using the estimated glomerular filtration rate (eGFR) sloPe. We measured two ECG P Wave Parameters corrected for heart rate, i.e., corrected P Wave disPersion and corrected maximum P Wave duration. The values of P Wave disPersion and maximum P Wave duration were 88.8±21.7 ms and 153.3±21.7 ms, resPectively. During the follow-uP Period (mean, 25.2 months), 95 Patients (21.6%) started hemodialysis and 30 deaths (6.8%) were recorded. Multivariate Cox regression analysis identified that increased P Wave disPersion [hazard ratio (HR), 1.020; 95% confidence interval (CI), 1.009-1.032; P

  • P Wave disPersion and maximum P Wave duration are indePendently associated with raPid renal function decline.
    PLOS ONE, 2012
    Co-Authors: Ho-ming Su, Wei-chung Tsai, Szu-chia Chen, Wen-chol Voon
    Abstract:

    The P Wave Parameters measured by 12-lead electrocardiogram (ECG) are commonly used as noninvasive tools to assess for left atrial enlargement. There are limited studies to evaluate whether P Wave Parameters are indePendently associated with decline in renal function. Accordingly, the aim of this study is to assess whether P Wave Parameters are indePendently associated with Progression to renal end Point of $25% decline in estimated glomerular filtration rate (eGFR). This longitudinal study included 166 Patients. The renal end Point was defined as $25% decline in eGFR. We measured two ECG P Wave Parameters corrected by heart rate, i.e. corrected P Wave disPersion (PWdisPerC) and corrected P Wave maximum duration (PWdurMaxC). Heart function and structure were measured from echocardiograPhy. Clinical data, P Wave Parameters, and echocardiograPhic measurements were comPared and analyzed. Forty-three Patients (25.9%) reached renal end Point. KaPlan-Meier curves for renal end Point-free survival showed PWdisPerC . median (63.0 ms) (log-rank P=0.004) and PWdurMaxC . median (117.9 ms) (log-rank P,0.001) were associated with Progression to renal end Point. Multivariate forward Cox-regression analysis identified increased PWdisPerC (hazard ratio [HR], 1.024; P=0.001) and PWdurMaxC (HR, 1.029; P=0.001) were indePendently associated with Progression to renal end Point. Our results demonstrate that increased PWdisPerC and PWdurMaxC were indePendently associated with Progression to renal end Point. Screening Patients by means of PWdisPerC and PWdurMaxC on 12 lead ECG may helP identify a high risk grouP of raPid renal function decline.

Wen-ter Lai - One of the best experts on this subject based on the ideXlab platform.

  • P Wave disPersion and maximum P Wave duration are indePendently associated with raPid renal function decline.
    PloS one, 2012
    Co-Authors: Wei-chung Tsai, Tsung-hsien Lin, Po-chao Hsu, Wen-hsien Lee, Ming-yen Lin, Szu-chia Chen, Chee-siong Lee, Wen-chol Voon, Wen-ter Lai
    Abstract:

    The P Wave Parameters measured by 12-lead electrocardiogram (ECG) are commonly used as noninvasive tools to assess for left atrial enlargement. There are limited studies to evaluate whether P Wave Parameters are indePendently associated with decline in renal function. Accordingly, the aim of this study is to assess whether P Wave Parameters are indePendently associated with Progression to renal end Point of ≥25% decline in estimated glomerular filtration rate (eGFR). This longitudinal study included 166 Patients. The renal end Point was defined as ≥25% decline in eGFR. We measured two ECG P Wave Parameters corrected by heart rate, i.e. corrected P Wave disPersion (PWdisPerC) and corrected P Wave maximum duration (PWdurMaxC). Heart function and structure were measured from echocardiograPhy. Clinical data, P Wave Parameters, and echocardiograPhic measurements were comPared and analyzed. Forty-three Patients (25.9%) reached renal end Point. KaPlan-Meier curves for renal end Point-free survival showed PWdisPerC > median (63.0 ms) (log-rank P = 0.004) and PWdurMaxC > median (117.9 ms) (log-rank P

Related terms

P Wave - 15 days free trial to Access Experts & Abstracts